Literature DB >> 9581764

Identification of a signaling pathway involved in calcium regulation of BDNF expression.

P B Shieh1, S C Hu, K Bobb, T Timmusk, A Ghosh.   

Abstract

A signaling pathway by which calcium influx regulates the expression of the major activity-dependent transcript of BDNF in cortical neurons has been elucidated. Deletion and mutational analysis of the promoter upstream of exon III reveals that transactivation of the BDNF gene involves two elements 5' to the mRNA start site. The first element, located between 72 and 47 bp upstream of the mRNA start site, is a novel calcium response element and is required for calcium-dependent BDNF expression in both embryonic and postnatal cortical neurons. The second element, located between 40 and 30 bp upstream of the mRNA start site, matches the consensus sequence of a cAMP response element (CRE) and is required for transactivation of the promoter in postnatal but not embryonic neurons. The CRE-dependent component of the response appears to be mediated by CREB since it is part of the complex that binds to this CRE, and since dominant negative mutants of CREB attenuate transactivation of the promoter. A constitutively active mutant of CaM kinase IV, but not of CaM kinase II, leads to activation of the promoter in the absence of extracellular stimuli, and partially occludes calcium-dependent transactivation. The effects of CaM kinase IV on the promoter require an intact CRE. These mechanisms, which implicate CaM kinase IV and CREB in the control of BDNF expression, are likely to be centrally involved in activity-dependent plasticity during development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581764     DOI: 10.1016/s0896-6273(00)81011-9

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  213 in total

1.  Differential roles of Ca(2+)/calmodulin-dependent protein kinase II and mitogen-activated protein kinase activation in hippocampal long-term potentiation.

Authors:  J Liu; K Fukunaga; H Yamamoto; K Nishi; E Miyamoto
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Regulated secretion of neurotrophins by metabotropic glutamate group I (mGluRI) and Trk receptor activation is mediated via phospholipase C signalling pathways.

Authors:  M Canossa; A Gärtner; G Campana; N Inagaki; H Thoenen
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

3.  Differential regulation by multiple promoters of the gene encoding the neuron-restrictive silencer factor.

Authors:  C Koenigsberger; J J Chicca; M C Amoureux; G M Edelman; F S Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  A relationship between behavior, neurotrophin expression, and new neuron survival.

Authors:  X C Li; E D Jarvis; B Alvarez-Borda; D A Lim; F Nottebohm
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 5.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

6.  Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

Authors:  Pierre Sokoloff; Olivier Guillin; Jorge Diaz; Patrick Carroll; Nathalie Griffon
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

7.  NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells.

Authors:  M Sato; K Suzuki; S Nakanishi
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

8.  Expression profiling to understand actions of NMDA/glutamate receptor antagonists in rat brain.

Authors:  Petri Törönen; Marcus Storvik; Anni-Maija Lindén; Outi Kontkane; Markéta Marvanová; Merja Lakso; Eero Castrén; Garry Wong
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

9.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

10.  L-type calcium channel-mediated plateau potentials in barrelette cells during structural plasticity.

Authors:  Fu-Sun Lo; Reha S Erzurumlu
Journal:  J Neurophysiol       Date:  2002-08       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.